COVID-19 Impact on Global Addictions Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Addictions Therapeutics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Addictions Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Alcohol Addiction Therapeutics
  • 1.4.3 Tobacco Addiction Therapeutics
  • 1.4.4 Drug Addiction Therapeutics
• 1.5 Market by Application
  • 1.5.1 Global Addictions Therapeutics Market Share by Application: 2020 VS 2026
  • 1.5.2 Public
  • 1.5.3 Private
  • 1.5.4 Government
• 1.6 Coronavirus Disease 2019 (Covid-19): Addictions Therapeutics Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Addictions Therapeutics Industry
    • 1.6.1.1 Addictions Therapeutics Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Addictions Therapeutics Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Addictions Therapeutics Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Addictions Therapeutics Market Perspective (2015-2026)
• 2.2 Addictions Therapeutics Growth Trends by Regions
  • 2.2.1 Addictions Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Addictions Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Addictions Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Addictions Therapeutics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Addictions Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Addictions Therapeutics Players by Market Size
  • 3.1.1 Global Top Addictions Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Addictions Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Addictions Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Addictions Therapeutics Market Concentration Ratio
  • 3.2.1 Global Addictions Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Addictions Therapeutics Revenue in 2019
• 3.3 Addictions Therapeutics Key Players Head office and Area Served
• 3.4 Key Players Addictions Therapeutics Product Solution and Service
• 3.5 Date of Enter into Addictions Therapeutics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Addictions Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Addictions Therapeutics Forecasted Market Size by Type (2021-2026)

5 Addictions Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Addictions Therapeutics Market Size by Application (2015-2020)
• 5.2 Global Addictions Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Addictions Therapeutics Market Size (2015-2020)
• 6.2 Addictions Therapeutics Key Players in North America (2019-2020)
• 6.3 North America Addictions Therapeutics Market Size by Type (2015-2020)
• 6.4 North America Addictions Therapeutics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Addictions Therapeutics Market Size (2015-2020)
• 7.2 Addictions Therapeutics Key Players in Europe (2019-2020)
• 7.3 Europe Addictions Therapeutics Market Size by Type (2015-2020)
• 7.4 Europe Addictions Therapeutics Market Size by Application (2015-2020)

8 China

• 8.1 China Addictions Therapeutics Market Size (2015-2020)
• 8.2 Addictions Therapeutics Key Players in China (2019-2020)
• 8.3 China Addictions Therapeutics Market Size by Type (2015-2020)
• 8.4 China Addictions Therapeutics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Addictions Therapeutics Market Size (2015-2020)
• 9.2 Addictions Therapeutics Key Players in Japan (2019-2020)
• 9.3 Japan Addictions Therapeutics Market Size by Type (2015-2020)
• 9.4 Japan Addictions Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Addictions Therapeutics Market Size (2015-2020)
• 10.2 Addictions Therapeutics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Addictions Therapeutics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Addictions Therapeutics Market Size by Application (2015-2020)

11 India

• 11.1 India Addictions Therapeutics Market Size (2015-2020)
• 11.2 Addictions Therapeutics Key Players in India (2019-2020)
• 11.3 India Addictions Therapeutics Market Size by Type (2015-2020)
• 11.4 India Addictions Therapeutics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Addictions Therapeutics Market Size (2015-2020)
• 12.2 Addictions Therapeutics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Addictions Therapeutics Market Size by Type (2015-2020)
• 12.4 Central & South America Addictions Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Alkermes Plc
  • 13.1.1 Alkermes Plc Company Details
  • 13.1.2 Alkermes Plc Business Overview and Its Total Revenue
  • 13.1.3 Alkermes Plc Addictions Therapeutics Introduction
  • 13.1.4 Alkermes Plc Revenue in Addictions Therapeutics Business (2015-2020))
  • 13.1.5 Alkermes Plc Recent Development
• 13.2 Amneal Pharmaceuticals Inc.
  • 13.2.1 Amneal Pharmaceuticals Inc. Company Details
  • 13.2.2 Amneal Pharmaceuticals Inc. Business Overview and Its Total Revenue
  • 13.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Introduction
  • 13.2.4 Amneal Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.2.5 Amneal Pharmaceuticals Inc. Recent Development
• 13.3 Indivior Plc
  • 13.3.1 Indivior Plc Company Details
  • 13.3.2 Indivior Plc Business Overview and Its Total Revenue
  • 13.3.3 Indivior Plc Addictions Therapeutics Introduction
  • 13.3.4 Indivior Plc Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.3.5 Indivior Plc Recent Development
• 13.4 Johnson & Johnson Services Inc.
  • 13.4.1 Johnson & Johnson Services Inc. Company Details
  • 13.4.2 Johnson & Johnson Services Inc. Business Overview and Its Total Revenue
  • 13.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Introduction
  • 13.4.4 Johnson & Johnson Services Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.4.5 Johnson & Johnson Services Inc. Recent Development
• 13.5 Mylan NV
  • 13.5.1 Mylan NV Company Details
  • 13.5.2 Mylan NV Business Overview and Its Total Revenue
  • 13.5.3 Mylan NV Addictions Therapeutics Introduction
  • 13.5.4 Mylan NV Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.5.5 Mylan NV Recent Development
• 13.6 Novartis AG
  • 13.6.1 Novartis AG Company Details
  • 13.6.2 Novartis AG Business Overview and Its Total Revenue
  • 13.6.3 Novartis AG Addictions Therapeutics Introduction
  • 13.6.4 Novartis AG Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.6.5 Novartis AG Recent Development
• 13.7 Novo Nordisk AS
  • 13.7.1 Novo Nordisk AS Company Details
  • 13.7.2 Novo Nordisk AS Business Overview and Its Total Revenue
  • 13.7.3 Novo Nordisk AS Addictions Therapeutics Introduction
  • 13.7.4 Novo Nordisk AS Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.7.5 Novo Nordisk AS Recent Development
• 13.8 Opiant Pharmaceuticals Inc.
  • 13.8.1 Opiant Pharmaceuticals Inc. Company Details
  • 13.8.2 Opiant Pharmaceuticals Inc. Business Overview and Its Total Revenue
  • 13.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Introduction
  • 13.8.4 Opiant Pharmaceuticals Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.8.5 Opiant Pharmaceuticals Inc. Recent Development
• 13.9 Pfizer Inc.
  • 13.9.1 Pfizer Inc. Company Details
  • 13.9.2 Pfizer Inc. Business Overview and Its Total Revenue
  • 13.9.3 Pfizer Inc. Addictions Therapeutics Introduction
  • 13.9.4 Pfizer Inc. Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.9.5 Pfizer Inc. Recent Development
• 13.10 Teva Pharmaceutical Industries Ltd.
  • 13.10.1 Teva Pharmaceutical Industries Ltd. Company Details
  • 13.10.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  • 13.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Introduction
  • 13.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Addictions Therapeutics Business (2015-2020)
  • 13.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer